Jakob, Jens <br/><br/>
Impact of preoperative treatment on the CINSARC prognostic signature: translational research results from a phase 1 trial of the German Interdisciplinary Sarcoma Group (GISG 03).  [electronic resource] 

 -  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]  Mar 2020 
 - 280-285 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1439-099X 
<br/><br/><label>Standard No.: </label>10.1007/s00066-019-01543-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor--analysis<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Germany--epidemiology<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--diagnosis<br/>Preoperative Care--methods<br/>Prognosis<br/>Risk Factors<br/>Sarcoma--diagnosis<br/>Sunitinib--therapeutic use<br/>Transcriptome<br/>Translational Research, Biomedical